Overexpression of wild type RRAS2, without oncogenic mutations, drives chronic lymphocytic leukemia.

Mol Cancer · 2022 · PMC8815240 · PMID 35120522

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The analysis of RRAS2 expression according to the unmutated vs mutated status of the IgHV region showed a higher mean for the IGHV-UM than for the IGHV-M CLL, although those differences did not reach statistical significance (Fig. 5 f).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.